Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation

Cell Calcium

Volumn 55, Issue 3, 2014, Pages 146-154

  Prendergast, Clodagh ^a   Quayle, John ^a   Burdyga, Theodor ^a   Wray, Susan ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apolipoprotein E knockout mice; Calcium signalling; Endothelium; Hypercholesterolaemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOLIPOPROTEIN E; CALCIUM ION; CARBACHOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHYL BETA CYCLODEXTRIN; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; CHOLESTEROL;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR RING; VASODILATATION; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERY CONSTRICTION; ARTERY DILATATION; HYPERCHOLESTEROLEMIA; INTRACELLULAR SIGNALING; MALE; THORACIC AORTA; ANIMAL; AORTA; AREA UNDER THE CURVE; C57BL MOUSE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC;

MUS;

ANIMALS; AORTA; APOLIPOPROTEINS E; AREA UNDER CURVE; ATHEROSCLEROSIS; CALCIUM SIGNALING; CARBACHOL; CHOLESTEROL; ENDOTHELIAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ROC CURVE;

EID: 84899913253     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.02.012     Document Type: Article

References (53)

1. Cohen A.W., Hnasko R., Shubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol. Rev. 2004, 84:1341-1379.
2. Lusis A.J., Mar R., Pajukanta P. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 2004, 5:189-218.
3. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
4. Chiu J., Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 2011, 91:327-387.
5. Mitra S., Deshmukh A., Sachdeva R., Lu J., Mehta J.L. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am. J. Med. Sci. 2011, 342:135-142.
6. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
7. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:243-253.
8. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994, 4:33-40.
9. Plump A.S., Breslow J.L. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu. Rev. Nutr. 1995, 15:495-518.
10. Crawels H.M., Van Hove C.E., Holvoet P., Herman A.G., Bult H. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human Apolipoprotein AI. Cardiovasc. Res. 2003, 59:189-199.
11. Kauser K., da Cunha V., Fitch R., Mallari C., Rubanyi G.M. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1679-H1685.
12. Fransen P., Van Assche T., Guns P.J., Van Hove C.E., De Keulenaer G.W., Herman A.G., Bult H. Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Pflugers Arch. 2008, 455:811-818.
13. Frank P.G., Lee H., Park D., Tandon N.N., Scherer P.E., Lisanti M.P. Genetic ablation of Caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:98-105.
14. 2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 1989, 264:17816-17823.
15. 2+-ATPase inhibitor, on contractile responses in skinned ileal smooth muscle. Br. J. Pharmacol. 1992, 106:208-214.
16. Bird G.S., DeHaven W.I., Smyth J.T., Putney J.E. Methods for studying store-operated calcium entry. Methods 2008, 46:204-212.
17. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41:19-26.
18. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 1995, 270:17250-17256.
19. Yancey P.G., Rodrigueza W.V., Kilsdonk E.P., Stoudt G.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 1996, 271:6026-6034.
20. Smith R.D., Babiychuk E.B., Noble K., Draeger A., Wray S. Increased cholesterol decreases uterine activity: functional effects of cholesterol in pregnant rat myometrium. Am. J. Physiol. 2005, 288:C982-C988.
21. Thomas S.R., Witting P.K., Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 2008, 10:1713-1765.
22. 2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions. Cell Calcium 2007, 41:295-302.
23. Kaiser R.A., Oxhorn B.C., Andrews G., Buxton I.L. Functional compartmentation of endothelial P2Y receptor signalling. Circ. Res. 2002, 91:292-299.
24. Paffett M.L., Naiks J.S., Riddle M.A., Menicucci S.D., Gonzales A.J., Resta T.C., Walker B.R. Altered membrane lipid domains limit pulmonary endothelial calcium entry following chronic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1331-H1340.
25. 2+ waves in bovine aortic endothelial cells. J. Cell. Biochem. 2009, 106:344-352.
26. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1267-1272.
27. Cristofaro V., Peters C.A., Yalla S.V., Sullivan M.P. Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions. Neurourol. Urodyn. 2007, 26:71-80.
28. 2+ signalling in a stimulus-specific manner. Cell Calcium 2010, 47:84-91.
29. Floyd R., Wray S. Calcium transporters and signaling in smooth muscles. Cell Calcium 2007, 42:467-476.
30. 2+ handling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L1226-L1235.
31. 2+ entry dependent on TRPC-1. Circ. Res. 2003, 93:839-847.
32. Pouvreau S., Berthier C., Blaineau S., Amsellem J., Coronado R., Strube C. Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells. J. Physiol. 2004, 555:365-381.
33. 2+ spark coupling in murine arterial smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2309-H2319.
34. 2+ homeostasis of single smooth muscle cells from rat cerebral resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H204-H214.
35. Murata T., Lin M.I., Stan R.V., Bauer P.M., Yu J., Sessa W.C. Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J. Biol. Chem. 2007, 282:16631-16643.
36. 2+ entry. Biochim. Biophys. Acta 2010, 1803:1083-1093.
37. Dopico A.M., Bukiya A.N., Singh A.K. Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol. Pharmacol. Ther. 2012, 135:133-150.
38. 2+ mobilization and contraction in airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L1406-L1418.
39. Chen H.I., Huang Y.C., Su W.H., Jen C.J. Endothelial calcium signalling in rabbit arteries and its local alterations in early-stage atherosclerosis. J. Biomed. Sci. 2007, 14:145-153.
40. Ragazzi, Chinellato A., De Biasi M., Pandolfo L., Prosdocimi M., Norido F., Caparrotta L., Fassina G. Endothelium-dependent relaxation, cholesterol content and high energy metabolite balance in Watanabe hyperlipidemic rabbit aorta. Atherosclerosis 1989, 80:125-134.
41. Chinelatto A., Banchieri N., Pandolfo L., Ragazzi E., Froldi G., Norido F., Caparrotta L., Fassina G. Aortic response to relaxing agents in Watanabe heritable hyperlipidemic (WHHL) rabbits of different age. Atherosclerosis 1991, 89:223-230.
42. Murata T., Sato K., Hori M., Ozaki H., Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J. Biol. Chem. 2002, 277:44085-44092.
43. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 1995, 96:60-68.
44. Nava, Farré A.L., Moreno C., Casado S., Moreau P., Cosentino F., Lüscher T.F. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J. Hypertens. 1998, 16:609-615.
45. 2+ entry. J. Biol. Chem. 2000, 275:17979-17985.
46. Kawashima S. Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase/NO system in atherosclerosis. J. Pharmacol. Sci. 2004, 96:411-419.
47. Landmesser U., Homig B., Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 2004, 109:II27-II33.
48. Polacek D., Bech F., McKinsey J.F., Davies P.F. Connexin43 gene expression in the rabbit arterial wall: effects of hypercholesterolemia, balloon injury and their combination. J. Vasc. Res. 1997, 34:19-30.
49. Yeh H.I., Lu C.S., Wu Y.J., Chen C.C., Hong R.C., Ko Y.S., Shiao M.S., Severs N.J., Tsai C.H. Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1391-1397.
50. Javid P.J., Watts S.W., Webb R.C. Inhibition of nitric oxide-induced vasodilation by gap junction inhibitors: a potential role for a cGMP-independent nitric oxide pathway. J. Vasc. Res. 1996, 33:395-404.
51. Chaytor A.T., Marsh W.L., Hutcheson I.R., Griffith T.M. Comparison of glycyrrhetinic acid isoforms and carbenoxalone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium 2000, 7:265-278.
52. de Wit C., Roos F., Bolz S.S., Kirchhoff S., Krüger O., Willecke K., Pohl U. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ. Res. 2000, 86:649-655.
53. 2+ signaling underlies suppressed endothelial nitric oxide production in preeclamptic pregnancies: implications for new therapy. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H969-H979.